H

Hospital Mãe de Deus | Clinical Research of Oncology and Hematology

Research site
(Unclaimed)
Location
Rua Costa, 30, Porto Alegre, Rio Grande do Sul, Brazil
Site insights

Top conditions

Uterine Cervical Cancer (3 trials)

COVID-19 (3 trials)

Pneumonia (2 trials)

Coronary Artery Disease (2 trials)

Lactose Intolerance (2 trials)

Top treatments

Leronlimab
AGEN2034
Rofecoxib
5-Fluorouracil
Lactase
Dapagliflozin
DP-b99
Gemcitabine
EVOLocumab
Cetuximab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 22
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

The primary objective of this study is to evaluate the effectiveness of early treatment with evolocumab plus routine lipid management vs routine lipi...

Enrolling
Stroke
Myocardial Infarction
Drug: Evolocumab
Drug: Routine Lipid Management

This is a randomized, blinded, non-comparative, two-arm Phase 2 clinical trial to assess the efficacy and safety of AGEN2034 administered with placeb...

Active, not recruiting
Cervical Cancer
Drug: AGEN2034
Drug: AGEN1884
Recently updated

This trial is being done to find out whether tisotumab vedotin works better than chemotherapy to treat cervical cancer. People in this study have cer...

Enrolling
Cervical Cancer
Drug: tisotumab vedotin
Drug: gemcitabine

Trial sponsors

Agenus logo

Agenus (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems